Scotts Miracle-Gro Past Earnings Performance
Past criteria checks 0/6
Scotts Miracle-Gro's earnings have been declining at an average annual rate of -50%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 1.9% per year.
Key information
-50.0%
Earnings growth rate
-50.0%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 1.9% |
| Return on equity | n/a |
| Net Margin | -10.1% |
| Next Earnings Update | 31 Jul 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Scotts Miracle-Gro makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Mar 24 | 3,429 | -348 | 472 | 36 |
| 30 Dec 23 | 3,435 | -396 | 483 | 35 |
| 30 Sep 23 | 3,551 | -380 | 493 | 36 |
| 01 Jul 23 | 3,671 | -132 | 500 | 36 |
| 01 Apr 23 | 3,738 | -619 | 504 | 38 |
| 31 Dec 22 | 3,885 | -452 | 515 | 42 |
| 30 Sep 22 | 3,924 | -437 | 537 | 45 |
| 02 Jul 22 | 4,168 | -266 | 576 | 49 |
| 02 Apr 22 | 4,592 | 408 | 598 | 70 |
| 01 Jan 22 | 4,742 | 442 | 664 | 48 |
| 30 Sep 21 | 4,925 | 516 | 669 | 45 |
| 03 Jul 21 | 5,078 | 569 | 713 | 44 |
| 03 Apr 21 | 4,960 | 543 | 794 | 21 |
| 02 Jan 21 | 4,514 | 482 | 706 | 50 |
| 30 Sep 20 | 4,132 | 386 | 687 | 40 |
| 27 Jun 20 | 3,739 | 327 | 641 | 28 |
| 28 Mar 20 | 3,417 | 301 | 586 | 19 |
| 28 Dec 19 | 3,224 | 448 | 605 | 0 |
| 30 Sep 19 | 3,156 | 437 | 529 | 40 |
| 29 Jun 19 | 3,092 | 362 | 564 | 12 |
| 30 Mar 19 | 2,917 | 309 | 491 | 43 |
| 29 Dec 18 | 2,740 | 65 | 493 | 33 |
| 30 Sep 18 | 2,663 | 128 | 540 | 0 |
| 30 Jun 18 | 2,606 | 216 | 465 | 42 |
| 31 Mar 18 | 2,585 | 235 | 480 | 40 |
| 30 Dec 17 | 2,656 | 236 | 491 | 40 |
| 30 Sep 17 | 2,642 | 198 | 489 | 40 |
| 01 Jul 17 | 2,338 | 213 | 488 | -5 |
| 01 Apr 17 | 2,359 | 196 | 515 | -21 |
| 31 Dec 16 | 2,519 | 268 | 509 | -2 |
| 30 Sep 16 | 2,506 | 247 | 468 | 36 |
| 02 Jul 16 | 2,809 | 232 | 527 | 46 |
| 02 Apr 16 | 2,926 | 222 | 532 | 46 |
| 02 Jan 16 | 2,753 | 134 | 520 | 46 |
| 30 Sep 15 | 2,371 | 130 | 489 | 0 |
| 27 Jun 15 | 2,807 | 165 | 547 | 45 |
| 28 Mar 15 | 2,812 | 170 | 581 | 46 |
| 27 Dec 14 | 2,821 | 156 | 604 | 47 |
| 30 Sep 14 | 2,578 | 146 | 512 | 46 |
| 28 Jun 14 | 2,821 | 161 | 623 | 34 |
| 29 Mar 14 | 2,841 | 189 | 665 | 0 |
| 28 Dec 13 | 2,768 | 162 | 659 | 1 |
| 30 Sep 13 | 2,774 | 159 | 605 | 46 |
| 29 Jun 13 | 2,741 | 142 | 669 | 0 |
Quality Earnings: 0L45 is currently unprofitable.
Growing Profit Margin: 0L45 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0L45 is unprofitable, and losses have increased over the past 5 years at a rate of 50% per year.
Accelerating Growth: Unable to compare 0L45's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0L45 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: 0L45's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.